BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 11986342)

  • 1. Multiparameter flow cytometry as a tool for the detection of micrometastatic tumour cells in the sentinel lymph node procedure of patients with breast cancer.
    Leers MP; Schoffelen RH; Hoop JG; Theunissen PH; Oosterhuis JW; vd Bijl H; Rahmy A; Tan W; Nap M
    J Clin Pathol; 2002 May; 55(5):359-66. PubMed ID: 11986342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
    Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
    Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance.
    den Bakker MA; van Weeszenberg A; de Kanter AY; Beverdam FH; Pritchard C; van der Kwast TH; Menke-Pluymers M
    J Clin Pathol; 2002 Dec; 55(12):932-5. PubMed ID: 12461062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel node biopsy in ductal carcinoma in situ patients.
    Pendas S; Dauway E; Giuliano R; Ku N; Cox CE; Reintgen DS
    Ann Surg Oncol; 2000; 7(1):15-20. PubMed ID: 10674443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node micrometastasis as a predictor of axillary tumor burden.
    Dabbs DJ; Fung M; Landsittel D; McManus K; Johnson R
    Breast J; 2004; 10(2):101-5. PubMed ID: 15009035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of CK-IHC assay on serial frozen sections, the OSNA assay, and in combination for intraoperative evaluation of SLN metastases in breast cancer.
    Shigematsu H; Ozaki S; Yasui D; Zaitsu J; Taniyama D; Saitou A; Kuraoka K; Yamashiro H; Taniyama K
    Breast Cancer; 2018 Mar; 25(2):191-197. PubMed ID: 29094254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of CD44+CD24- cells on non-sentinel axillary lymph node metastases in sentinel node-positive breast cancer.
    Nogi H; Suzuki M; Kamio M; Kato K; Kawase K; Toriumi Y; Takeyama H; Fukushima H; Morikawa T; Uchida K
    Oncol Rep; 2011 Apr; 25(4):1109-15. PubMed ID: 21308353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage migration in breast cancer: surgical decisions concerning isolated tumour cells and micro-metastases in the sentinel lymph node.
    de Widt-Levert L; Tjan-Heijnen V; Bult P; Ruers T; Wobbes T
    Eur J Surg Oncol; 2003 Apr; 29(3):216-20. PubMed ID: 12657229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel Node Biopsy Examination for Breast Cancer in a Routine Laboratory Practice: Results of a Pilot Study.
    Khoo JJ; Ng CS; Sabaratnam S; Arulanantham S
    Asian Pac J Cancer Prev; 2016; 17(3):1149-55. PubMed ID: 27039740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
    Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
    Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Her2/neu analysis in formalin-fixed, paraffin-embedded breast carcinomas: comparison of immunohistochemistry and multiparameter DNA flow cytometry.
    Leers MP; Hoop JG; Nap M
    Anticancer Res; 2003; 23(2A):999-1006. PubMed ID: 12820338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the method of biopsy affect the incidence of sentinel lymph node metastases?
    Newman EL; Kahn A; Diehl KM; Cimmino VM; Kleer CA; Chang AE; Newman LA; Sabel MS
    Breast J; 2006; 12(1):53-7. PubMed ID: 16409587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection.
    Kamath VJ; Giuliano R; Dauway EL; Cantor A; Berman C; Ku NN; Cox CE; Reintgen DS
    Arch Surg; 2001 Jun; 136(6):688-92. PubMed ID: 11387010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One Step Nucleic Acid Amplification (OSNA) positive micrometastases and additional histopathological NSLN metastases: Results from a single institution over 53 months.
    Babar M; Madani R; Jackson P; Layer GT; Kissin MW; Irvine TE
    Surgeon; 2016 Apr; 14(2):76-81. PubMed ID: 25444440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer.
    Ozmen V; Karanlik H; Cabioglu N; Igci A; Kecer M; Asoglu O; Tuzlali S; Mudun A
    Breast Cancer Res Treat; 2006 Jan; 95(1):1-6. PubMed ID: 16322900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative imprint cytologic evaluation of sentinel lymph nodes for lobular carcinoma of the breast.
    Creager AJ; Geisinger KR; Perrier ND; Shen P; Shaw JA; Young PR; Case D; Levine EA
    Ann Surg; 2004 Jan; 239(1):61-6. PubMed ID: 14685101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of frozen section analysis of sentinel lymph nodes for the detection of Asian breast cancer micrometastasis - experience from Pakistan.
    Hashmi AA; Faridi N; Khurshid A; Naqvi H; Malik B; Malik FR; Fida Z; Mujtuba S
    Asian Pac J Cancer Prev; 2013; 14(4):2657-62. PubMed ID: 23725191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of occult metastases and isolated tumor cells in sentinel and non-sentinel lymph nodes in early breast cancer patients: serial step section analysis with long-term follow-up.
    Takeshita T; Tsuda H; Moriya T; Yamasaki T; Asakawa H; Ueda S; Sato K; Aida S; Tamai S; Matsubara O; Hase K; Yamamoto J
    Ann Surg Oncol; 2012 Apr; 19(4):1160-6. PubMed ID: 21989659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of sentinel lymph node biopsy between invasive lobular carcinoma and invasive ductal carcinoma.
    Adachi Y; Sawaki M; Hattori M; Yoshimura A; Gondo N; Kotani H; Iwase M; Kataoka A; Onishi S; Sugino K; Terada M; Horisawa N; Mori M; Oze I; Iwata H
    Breast Cancer; 2018 Sep; 25(5):560-565. PubMed ID: 29536376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological parameters and biological markers predicting non-sentinel node metastasis in sentinel node-positive breast cancer patients.
    Kwon Y; Ro J; Kang HS; Kim SK; Hong EK; Khang SK; Gong G; Ro JY
    Oncol Rep; 2011 Apr; 25(4):1063-71. PubMed ID: 21258771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.